Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

131 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy.
Hennessy BT, Hortobagyi GN, Rouzier R, Kuerer H, Sneige N, Buzdar AU, Kau SW, Fornage B, Sahin A, Broglio K, Singletary SE, Valero V. Hennessy BT, et al. J Clin Oncol. 2005 Dec 20;23(36):9304-11. doi: 10.1200/JCO.2005.02.5023. J Clin Oncol. 2005. PMID: 16361629
Proteomic classification of breast cancer.
Kamel D, Brady B, Tabchy A, Mills GB, Hennessy B. Kamel D, et al. Curr Drug Targets. 2012 Nov;13(12):1495-509. doi: 10.2174/138945012803530080. Curr Drug Targets. 2012. PMID: 22974393 Review.
Barriers to care for breast cancer: A qualitative study in Ireland.
Byrne J, Campbell H, Gilchrist M, Summersby E, Hennessy B. Byrne J, et al. Eur J Cancer Care (Engl). 2018 Sep;27(5):e12876. doi: 10.1111/ecc.12876. Epub 2018 Jul 20. Eur J Cancer Care (Engl). 2018. PMID: 30028056
[No authors listed] [No authors listed] PMID: 32018803
Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.
Symmans WF, Peintinger F, Hatzis C, Rajan R, Kuerer H, Valero V, Assad L, Poniecka A, Hennessy B, Green M, Buzdar AU, Singletary SE, Hortobagyi GN, Pusztai L. Symmans WF, et al. J Clin Oncol. 2007 Oct 1;25(28):4414-22. doi: 10.1200/JCO.2007.10.6823. Epub 2007 Sep 4. J Clin Oncol. 2007. PMID: 17785706
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.
Liedtke C, Mazouni C, Hess KR, André F, Tordai A, Mejia JA, Symmans WF, Gonzalez-Angulo AM, Hennessy B, Green M, Cristofanilli M, Hortobagyi GN, Pusztai L. Liedtke C, et al. J Clin Oncol. 2008 Mar 10;26(8):1275-81. doi: 10.1200/JCO.2007.14.4147. Epub 2008 Feb 4. J Clin Oncol. 2008. PMID: 18250347
Triple receptor-negative breast cancer: the effect of race on response to primary systemic treatment and survival outcomes.
Dawood S, Broglio K, Kau SW, Green MC, Giordano SH, Meric-Bernstam F, Buchholz TA, Albarracin C, Yang WT, Hennessy BT, Hortobagyi GN, Gonzalez-Angulo AM. Dawood S, et al. J Clin Oncol. 2009 Jan 10;27(2):220-6. doi: 10.1200/JCO.2008.17.9952. Epub 2008 Dec 1. J Clin Oncol. 2009. PMID: 19047281 Free PMC article.
The role of anthracyclines in the treatment of early breast cancer.
Greene J, Hennessy B. Greene J, et al. J Oncol Pharm Pract. 2015 Jun;21(3):201-12. doi: 10.1177/1078155214531513. Epub 2014 Apr 26. J Oncol Pharm Pract. 2015. PMID: 24769570 Review.
Economic impact of 21-gene recurrence score testing on early-stage breast cancer in Ireland.
Smyth L, Watson G, Walsh EM, Kelly CM, Keane M, Kennedy MJ, Grogan L, Hennessy BT, O'Reilly S, Coate LE, O'Connor M, Quinn C, Verleger K, Schoeman O, O'Reilly S, Walshe JM. Smyth L, et al. Breast Cancer Res Treat. 2015 Oct;153(3):573-82. doi: 10.1007/s10549-015-3555-4. Epub 2015 Sep 12. Breast Cancer Res Treat. 2015. PMID: 26364296 Clinical Trial.
131 results
Jump to page
Feedback